Boldever 250mg/ml 10ml Vial by Vermodje

Usage

1. Record the date of every Boldever injection throughout the cycle; the final injection date is the reference point from which the PCT clearance window is calculated.
2. During the four-to-five-week clearance window, maintain caloric sufficiency and continue resistance training to preserve as much cycle-gained lean mass as possible while avoiding any additional androgenic compounds.
3. Obtain a hormone panel — LH, FSH, total testosterone, and haematocrit — at the end of the clearance window and before the first SERM dose to establish a post-cycle baseline.
4. Begin SERM therapy (tamoxifen 20–40 mg/day or clomiphene 50 mg/day, per prescriber guidance) on the scheduled PCT start date, not before, to avoid wasting SERMs against residual androgenic suppression.
5. Run the SERM block for six to eight weeks; taper the dose progressively in the final two weeks rather than stopping abruptly to avoid a rebound drop in gonadotrophin output.
6. At the conclusion of the SERM block, repeat the full hormone and metabolic panel; confirm LH, FSH, total testosterone, HDL/LDL, and haematocrit have all normalised before planning any future protocol.

Warnings

Frequently asked questions

How many weeks after the last Boldever injection should PCT actually begin?

PCT should begin approximately four to five weeks after the final Boldever injection. The undecylenate ester continues releasing free boldenone for several weeks post-injection, keeping androgen-receptor signalling — and therefore HPTA suppression — active. Starting SERMs before this clearance window closes reduces their effectiveness, as residual hormone competes with the recovery signal.

Which SERM is recommended for Post-Cycle Therapy after a long-ester boldenone cycle?

Tamoxifen (Nolvadex) is the most commonly recommended SERM following a long-ester boldenone cycle due to its manageable side-effect profile and well-documented LH-stimulating effect. Clomiphene citrate can be added for stronger gonadotrophin stimulation in cases of deeper suppression, though it carries a higher incidence of mood and visual disturbances compared to tamoxifen alone.

How long does full hormonal recovery typically take after a Boldever cycle?

Most users require six to eight weeks of active SERM therapy after the clearance period, with total HPTA reinstatement — confirmed by LH, FSH, and total testosterone returning to pre-cycle reference ranges — occurring within ten to fourteen weeks of the final injection in uncomplicated cases. Longer or higher-dose Boldever cycles extend this timeline, making bloodwork the only reliable endpoint marker.

Can I draw partial doses from the Boldever 10ml vial accurately using an insulin syringe during a low-dose phase?

Yes. At 250 mg/ml, each 0.1 ml drawn on a standard 1 ml insulin syringe corresponds to 25 mg of boldenone undecylenate. Insulin syringes graduated in 0.01 ml increments therefore allow dose resolution of 2.5 mg per mark, making precise fractional draws practical for gradual dose-tapering protocols used in the weeks approaching the final injection before PCT begins.

How should the Boldever 10ml vial be stored after first puncture?

After the rubber septum has been first punctured, store the vial in a cool, dark environment — ideally 2–8 °C in a refrigerator — to preserve sterility and prevent the carrier oil from degrading. Allow the vial to reach room temperature before each draw. Once opened, the vial should be used within 28 days; inspect the solution visually for particulates or cloudiness before every injection and discard if either is present. (2) angle_used

Manufacturer

Vermodje SRL traces its origins to the Republic of Moldova, where it was established as one of the earliest licensed pharmaceutical manufacturers in that country to focus on injectable androgenic-anabolic steroids for the European market. The company's founding premise centred on bringing pharmaceutical-grade sterile production standards — including validated aseptic processes and rigorous finished-product testing — to a product category historically dominated by unlicensed clandestine laboratories. Vermodje's facility operates under GMP-aligned quality frameworks, with fill-finish operations conducted in controlled environments designed to meet injectable-grade sterility benchmarks. Boldever undergoes HPLC-based potency confirmation at the finished-product stage alongside endotoxin screening — analytical steps that distinguish a licensed manufacturer's output from unverified market alternatives and that give users reliable concentration data when structuring both cycle duration and the PCT timeline that follows.